Peak Bio Statistics
Total Valuation
Peak Bio has a market cap or net worth of $116,459. The enterprise value is $7.49 million.
| Market Cap | 116,459 |
| Enterprise Value | 7.49M |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
Peak Bio has 22.40 million shares outstanding. The number of shares has increased by 0.98% in one year.
| Shares Outstanding | 22.40M |
| Shares Change (YoY) | +0.98% |
| Shares Change (QoQ) | +2.10% |
| Owned by Insiders (%) | 41.02% |
| Owned by Institutions (%) | 16.00% |
| Float | 6.22M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.19 |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 12.05 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.08
| Current Ratio | 0.08 |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -4.14 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -1,430.76% |
| Return on Capital (ROIC) | n/a |
| Revenue Per Employee | $29,597 |
| Profits Per Employee | -$1.22M |
| Employee Count | 21 |
| Asset Turnover | 0.09 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Peak Bio has paid $534,665 in taxes.
| Income Tax | 534,665 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -99.00% in the last 52 weeks. The beta is 0.53, so Peak Bio's price volatility has been lower than the market average.
| Beta (1Y) | 0.53 |
| 52-Week Price Change | -99.00% |
| 50-Day Moving Average | 0.01 |
| 200-Day Moving Average | 0.22 |
| Relative Strength Index (RSI) | 32.27 |
| Average Volume (30 Days) | 437 |
Short Selling Information
The latest short interest is 29,055, so 0.13% of the outstanding shares have been sold short.
| Short Interest | 29,055 |
| Short Previous Month | 43,900 |
| Short % of Shares Out | 0.13% |
| Short % of Float | 0.47% |
| Short Ratio (days to cover) | 0.35 |
Income Statement
In the last 12 months, Peak Bio had revenue of $621,535 and -$25.69 million in losses. Loss per share was -$1.36.
| Revenue | 621,535 |
| Gross Profit | -2.89M |
| Operating Income | -20.50M |
| Pretax Income | -26.15M |
| Net Income | -25.69M |
| EBITDA | -16.14M |
| EBIT | -16.38M |
| Loss Per Share | -$1.36 |
Balance Sheet
The company has $214,369 in cash and $7.59 million in debt, giving a net cash position of -$7.37 million or -$0.33 per share.
| Cash & Cash Equivalents | 214,369 |
| Total Debt | 7.59M |
| Net Cash | -7.37M |
| Net Cash Per Share | -$0.33 |
| Equity / Book Value | -19.32M |
| Book Value Per Share | -0.86 |
| Working Capital | -16.50M |
Cash Flow
| Operating Cash Flow | -7.86M |
| Capital Expenditures | n/a |
| Free Cash Flow | -7.86M |
| FCF Per Share | -$0.39 |
Margins
Gross margin is -465.37%, with operating and profit margins of -3,299.03% and -4,132.53%.
| Gross Margin | -465.37% |
| Operating Margin | -3,299.03% |
| Pretax Margin | -4,207.16% |
| Profit Margin | -4,132.53% |
| EBITDA Margin | -2,596.58% |
| EBIT Margin | -2,635.89% |
| FCF Margin | -1,265.01% |
Dividends & Yields
Peak Bio does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.98% |
| Shareholder Yield | -0.98% |
| Earnings Yield | -22,055.07% |
| FCF Yield | -6,751.28% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | 85.65% |
| EPS Growth Forecast (5Y) | 4.87% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Peak Bio has an Altman Z-Score of -70.47 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -70.47 |
| Piotroski F-Score | 1 |